logo

For the Inventor, By the Inventor

Haverhill, MA, United States of America

David R Crockford

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: University Patents, Inc., Nuc Med Inc., Serono Laboratories, Inc.. Active years: 1982-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David R Crockford. Retrieved from https://idiyas.com/inventor/david-r-crockford

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 238(Granted Patents)


Location History:

  • Nashua, NH (US) (1982)
  • Haverhill, MA (US) (1982 - 1984)

Company Filing History:

goldMedal5 out of 224 
 
University Patents, Inc.
 patents
silverMedal3 out of 3 
 
Nuc Med Inc.
 patents
bronzeMedal1 out of 8 
 
Serono Laboratories, Inc.
 patents
4. 1 out of 2 
 
Summa Medical Corporation
 patents
where one patent can have more than one assignee

Years Active: 1982-1984

Loading Chart...
5 patents (USPTO):Explore Patents
1. 4478815 - Composition and method for detecting cancer with technetium labeled (1984-10-23),
2. 4472371 - Radiolabeled antibody to anti-tumor associated antigen and process (1984-09-18),
3. 4424200 - Method for radiolabeling proteins with technetium-99m (1984-01-03),
4. 4323546 - Method and composition for cancer detection in humans (1982-04-06),
5. 4311688 - Composition and method for cancer detection in humans (1982-01-19),

Title: David R. Crockford: Innovator in Cancer Detection Technologies

Introduction

David R. Crockford is a notable inventor based in Haverhill, MA (US), recognized for his significant contributions to cancer detection technologies. With a total of 5 patents, his work has advanced the field of medical diagnostics, particularly in the detection of tumors through innovative methods.

Latest Patents

Crockford's latest patents focus on compositions and methods for detecting cancer using technetium-labeled antibody fragments. One of his key inventions involves the use of F(ab').sub.2 or Fab fragments of antibodies that target specific tumor-associated molecules, such as human chorionic gonadotropin (hCG) and carcinoembryonic antigen (CEA). When these radiolabeled fragments are injected into a patient, they accumulate at tumor sites, allowing for detection through external gamma scintigraphy. This method enhances the monitoring and localization of cancer, providing a semi-noninvasive technique for tumor detection.

Career Highlights

Throughout his career, Crockford has worked with various organizations, including University Patents, Inc. and Nuc Med Inc. His innovative approaches have contributed to the development of advanced diagnostic tools that improve cancer detection and patient outcomes.

Collaborations

Crockford has collaborated with notable professionals in the field, including Buck A. Rhodes and Scott W. Burchiel. These partnerships have fostered the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

David R. Crockford's work in cancer detection technologies exemplifies the importance of innovation in medical diagnostics. His patents and collaborations have paved the way for advancements that can significantly improve the early detection and treatment of cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…